ASCENSIA DIABETES CARE US H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ASCENSIA DIABETES CARE US is $134,798, based on 20 certified filings from FY 2020 to FY 2026. This is 12% higher than the national H-1B median salary of $120,000. Compensation at ASCENSIA DIABETES CARE US reflects their market positioning, with entry-level roles starting around $125,000 and senior positions reaching $161,200 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ASCENSIA DIABETES CARE US range from $110,000 at the 10th percentile to $161,200 at the 90th percentile, showing a $51,200 spread across experience levels and roles. The 25th percentile is $125,000 and the 75th percentile is $145,000.

Yes, ASCENSIA DIABETES CARE US actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 20 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 20 certified applications and a 0% denial rate, ASCENSIA DIABETES CARE US maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ASCENSIA DIABETES CARE US filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, ASCENSIA DIABETES CARE US has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ASCENSIA DIABETES CARE US's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 20 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ASCENSIA DIABETES CARE US as a potential H-1B sponsor.

This is an excellent approval rate, indicating ASCENSIA DIABETES CARE US has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

ASCENSIA DIABETES CARE US sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 20 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ASCENSIA DIABETES CARE US most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ASCENSIA DIABETES CARE US:

The most frequently sponsored role is Quality Manager Post-Market Surveillance with 2 filings at a median salary of $134,798. This is followed by Regulatory Affairs Manager (2 filings) and IT Architect - Netsuite.

ASCENSIA DIABETES CARE US's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ASCENSIA DIABETES CARE US sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ASCENSIA DIABETES CARE US H-1B locations:

The largest H-1B hub for ASCENSIA DIABETES CARE US is Parsippany, NJ with 9 filings at a median salary of $135,000. The highest-paying location is Willamsburg, MI at $176,407 median. Salaries range from $100,000 to $176,407 across office locations.

ASCENSIA DIABETES CARE US's median H-1B salary has increased by +27% from FY 2020 ($110,000) to FY 2026 ($140,000). Tracking salary trends over time reveals how ASCENSIA DIABETES CARE US adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ASCENSIA DIABETES CARE US.

Year-by-year breakdown:

• FY 2022: $145,000 (4 certified)
• FY 2023: $134,798 (2 certified)
• FY 2024: $144,891 (1 certified)
• FY 2025: $137,627 (4 certified)
• FY 2026: $140,000 (1 certified)

This 27% growth reflects strong compensation adjustments at ASCENSIA DIABETES CARE US, keeping pace with market demands for H-1B talent.

ASCENSIA DIABETES CARE US primarily files H-1B applications at Wage Level IV, accounting for 60% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ASCENSIA DIABETES CARE US's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 100% of positions at Level II or higher, ASCENSIA DIABETES CARE US typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

ASCENSIA DIABETES CARE US's median H-1B salary of $134,798 is 12% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ASCENSIA DIABETES CARE US's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ASCENSIA DIABETES CARE US's offerings with similar companies in your field for a more accurate assessment.

ASCENSIA DIABETES CARE US offers above-average H-1B compensation. Combined with their 20 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ASCENSIA DIABETES CARE US's higher proportion of Level III-IV positions (75%) may benefit from wage-based lottery prioritization.

With 20 certified filings, ASCENSIA DIABETES CARE US invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.